T 0975/16 (LAG-3 on regulatory T cells/JOHNS HOPKINS) of 28.10.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T097516.20211028
- Date of decision
- 28 October 2021
- Case number
- T 0975/16
- Petition for review of
- -
- Application number
- 07021595.9
- IPC class
- A61K 39/38C12N 5/071C07K 16/28C12N 5/074C12P 21/08C12N 15/63A61K 39/395A61K 39/00C07K 16/00A61K 31/70C07K 14/705G01N 33/53A01N 43/04C12N 5/0783
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- T cell regulation
- Applicant name
- The Johns Hopkins University
St. Jude Children's Research Hospital Inc. - Opponent name
- 4-ANTIBODY AG
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal 2020 Art 013(2)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Amendments - allowable (yes)
Novelty - main request (no)
Novelty - auxiliary request 1 (no)
Novelty - auxiliary request 2 (yes)
Inventive step - auxiliary request 2 (yes)
Sufficiency of disclosure - auxiliary request 2 (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in amended form on the basis of the set of claims of the auxiliary request 2 filed with the statement of grounds and a description as well as drawings possibly to be adapted thereto.